AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2015

Jun 3, 2015

29777_dirs_2015-06-03_e7e70137-4539-4579-80d1-5210e7c8bd98.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2015-06-01

Reporting Person: LANE ANDREW H (Senior Vice President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-01	Option (right to buy)	$48.90	A	114692	Acquired	2025-05-31	Common shares (114692)	Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 38,231 on 6/1/2016, 38,230 on 6/1/2017, and 38,231 on 6/1/2018.